Aim: analysis of diagnostic possibilities of early and late forms of fetal growth retardation (FGR) based on the study of autoimmune antibodies (АВ).Materials and Methods. A single center prospective cohort comparative study included 98 pregnant women: 79 with FGR (main group I) and 19 with physiological course of pregnancy (comparison group II). Pregnant women with FGR, depending on the time of manifestation, were divided into 2 subgroups: early form of FGR (group IA), late form of FGR (group IB). All patients underwent venous blood sampling to determine the serum content of autoimmune AB in 12 antigens using the Eli-P-test: for human chorionic gonadotropin antigen (hCG), for DNA, for β2-glycoprotein (β2-GP), for collagen, for fragment crystallizable of immunoglobulin G (Fc-IgG), for insulin, for thyroglobulin, for S100 protein, for surface antigen of germ cell and prostate (Spr), for thrombocyte membrane protein (TrM), for anti-neutrophil cytoplasmic antibodies (ANCA), for membrane antigen of glomerular cells (KiMS). Venous blood sampling was carried out in the main group at the time of diagnosis of FGR: with early manifestation of FGR – 29 [28; 31] weeks, with late manifestation of FGR – 5 [33; 36] weeks, in the comparison group II – 33 [32; 35] weeks.Results. For the diagnosis of an early form of FGR, statistical significance was shown by an increase in the level of the following autoimmune antibodies: АВ to hCG, to collagen, to S100 protein, to TrM, to ANCA, to KiMS (p = 0.037; р = 0.001; р = 0.013; р = 0.005; р = 0.003; p < 0.001, respectively), and for the diagnosis of late form of FGR – АВ to DNA, to collagen, to insulin, to S100 protein (p = 0.002; p = 0.003; p = 0.010; p < 0.001, respectively).Conclusion. АТ determination has shown its informative value in pregnant women with FGR, changes in the level of autoantibodies can act as a laboratory marker of early and late forms of FGR.